The Procter & Gamble Company (NYSE:PG – Get Free Report) fell 0% during mid-day trading on Friday . The company traded as low as $170.12 and last traded at $170.77. 781,439 shares changed hands during trading, a decline of 88% from the average session volume of 6,673,486 shares. The stock had previously closed at $170.85.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on PG. Evercore ISI upped their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research report on Monday, October 21st. Morgan Stanley upped their price objective on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a report on Monday, October 21st. Barclays lowered Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective on the stock. in a research report on Monday, September 30th. Royal Bank of Canada restated a “sector perform” rating and issued a $164.00 target price on shares of Procter & Gamble in a research report on Monday, October 21st. Finally, DA Davidson upgraded shares of Procter & Gamble from a “neutral” rating to a “buy” rating and increased their price target for the company from $160.00 to $209.00 in a research report on Monday, November 25th. Eight analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Procter & Gamble currently has an average rating of “Moderate Buy” and an average target price of $180.45.
View Our Latest Analysis on PG
Procter & Gamble Trading Up 0.1 %
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. During the same period in the previous year, the firm earned $1.83 EPS. The company’s quarterly revenue was down .6% compared to the same quarter last year. On average, research analysts forecast that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.
Procter & Gamble Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a $1.0065 dividend. The ex-dividend date was Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.35%. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, CEO Jon R. Moeller sold 7,007 shares of the firm’s stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the completion of the transaction, the chief executive officer now owns 269,172 shares of the company’s stock, valued at approximately $46,203,373.80. This trade represents a 2.54 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Gary A. Coombe sold 47,847 shares of the company’s stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the sale, the chief executive officer now directly owns 39,977 shares in the company, valued at $7,189,463.68. This represents a 54.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 83,080 shares of company stock valued at $14,629,038. 0.18% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Procter & Gamble
Hedge funds have recently bought and sold shares of the business. Brass Tax Wealth Management Inc. boosted its position in shares of Procter & Gamble by 0.3% in the 3rd quarter. Brass Tax Wealth Management Inc. now owns 49,582 shares of the company’s stock worth $8,588,000 after purchasing an additional 131 shares in the last quarter. 1ST Source Bank raised its stake in Procter & Gamble by 10.4% during the third quarter. 1ST Source Bank now owns 55,872 shares of the company’s stock valued at $9,677,000 after buying an additional 5,255 shares during the last quarter. DGS Capital Management LLC bought a new stake in Procter & Gamble in the third quarter worth $267,000. Copley Financial Group Inc. purchased a new stake in shares of Procter & Gamble in the third quarter worth $668,000. Finally, Retirement Systems of Alabama increased its holdings in shares of Procter & Gamble by 13.6% during the third quarter. Retirement Systems of Alabama now owns 1,059,739 shares of the company’s stock valued at $183,547,000 after acquiring an additional 126,865 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- How to Read Stock Charts for Beginners
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to Plot Fibonacci Price Inflection Levels
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What Are Dividends? Buy the Best Dividend Stocks
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.